Abstract:Objective To prepare and identify monoclonal antibodies against human IL-17C. Methods The monoclonal antibodies against human IL-17C(mAbs) with hybridoma technique using six-week-old female BALB/c mice. The titers, cross-reactivity, specificity and subclass of the mAbs were determined. The applicability of the mAb was verified by immunoassay, and the mAb 7F10 was used as primary antibody for immunofluorescence and immunohistochemistry analysis. Results Nine hybridoma clones stably secreting mAb against human IL-17C were successfully screened out and named as 1F11, 3A3, 7F10, 9B3, 10C6, 10A7, 10B10, 12F1 and 12F7, which all possessed significant receptor-blocking activity. Further studies showed that clone 7F10 and 10A7 could cause a cross-reaction between human and mouse IL-17C; and no cross-reactivity between mAb 7F10 or 10A7 and other members of the IL-17 family was observed. Both 7F10 and 10A7 were the IgG1 subclass antibodies, and the light chain was kappa type. The mAb 7F10 as primary antibody was successfully applied in immunofluorescence and immunohistochemistry assays. Conclusion The monoclonal antibodies against human IL-17C have been successfully prepared, among which 7F10 can be successfully applied in immunofluorescence and immunohistochemical detection, indicating that 7F10 may be used for diagnosis and treatment of IL-17C-associated diseases clinically.